Session I. After the Clinical Trial? Then What?
Discussion Leaders: Marian C. Limacher, M.D., Professor of Medicine, University of Florida College of Medicine, Gainesville, Florida, and Deneen Robinson, B.S.W., HIV Treatment Consultant, Dallas, Texas

Session II. Minority Investigators in Clinical Trials? How Important Are They?
Discussion Leaders: Clemente Diaz, M.D., Professor and Chairman, Department of Pediatrics, University of Puerto Rico, San Juan, Puerto Rico, and Michele K. Evans, M.D., Deputy Scientific Director, Intramural Research Program, National Institute on Aging, NIH, Baltimore, Maryland

Session III. Role of the Community Advisory Board and Outreach Activities
Discussion Leaders: Anne Madey, R.N., Research Nurse Coordinator, University of Tennessee Health Science Center, Memphis, Tennessee, and Matthew Murguia, Director, Office of Program Operations and Scientific Information, Division of AIDS, NIAID, NIH, Bethesda, Maryland